KBC Group’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$39K Hold
2,011
﹤0.01% 1735
2025
Q4
$44K Sell
2,011
-189,826
-99% -$3.43M ﹤0.01% 1671
2025
Q3
$2.33M Hold
191,837
0.01% 568
2025
Q2
$3.58M Sell
191,837
-1,971
-1% -$39K 0.01% 500
2025
Q1
$3.71M Buy
193,808
+1,329
+0.7% +$38.9K 0.01% 501
2024
Q4
$6.93M Buy
192,479
+56,461
+42% +$1.91M 0.02% 436
2024
Q3
$5.77M Sell
136,018
-103,396
-43% -$4.38M 0.02% 452
2024
Q2
$9.65M Sell
239,414
-530
-0.2% -$22.1K 0.03% 343
2024
Q1
$8.5M Hold
239,944
0.03% 365
2023
Q4
$7.1M Buy
239,944
+110,630
+86% +$2.3M 0.03% 406
2023
Q3
$2.69M Buy
129,314
+61,940
+92% +$1.7M 0.01% 542
2023
Q2
$1.65M Sell
67,374
-551
-0.8% -$17.7K 0.01% 625
2023
Q1
$2.76M Buy
67,925
+5,276
+8% +$218K 0.01% 601
2022
Q4
$2.82M Buy
62,649
+1,149
+2% +$52K 0.01% 542
2022
Q3
$2.94M Hold
61,500
0.02% 484
2022
Q2
$3.64M Sell
61,500
-12,647
-17% -$1.04M 0.02% 450
2022
Q1
$8.62M Sell
74,147
-15,705
-17% -$1.83M 0.03% 346
2021
Q4
$13.5M Buy
89,852
+28,695
+47% +$3.87M 0.04% 308
2021
Q3
$7.3M Buy
+61,157
New +$6.74M 0.03% 408

Other funds holding TNDM

KBC Group's TNDM Position: Q1 2026 in Review

KBC Group held its Tandem Diabetes Care (TNDM) position steady in Q1 2026 at 2,011 shares worth $39K. The position accounts for ﹤0.01% of the portfolio, ranked #1735.

KBC Group first reported a position in TNDM in Q3 2021 and has held it in 19 quarters since. The position peaked at $13.5M in Q4 2021. 272 funds tracked by Wall St. Rank hold TNDM as of Q1 2026.

  • KBC Group held 2,011 shares of Tandem Diabetes Care worth $39K as of Q1 2026.
  • KBC Group left its Tandem Diabetes Care share count unchanged in Q1 2026.
  • Tandem Diabetes Care made up ﹤0.01% of KBC Group's portfolio in Q1 2026, its #1735 holding.
  • KBC Group first reported a position in Tandem Diabetes Care in Q3 2021 and has held it in 19 quarters since.
  • KBC Group's Tandem Diabetes Care position peaked at $13.5M in Q4 2021.
  • 272 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2026.

Based on KBC Group's 13F filing for Q1 2026, filed 7 May 2026.